Sarcopenia Treatment Market Size, Share

Global Sarcopenia Treatment Market Research Report: Forecast (2025-2030)

Sarcopenia Treatment Market Report - By Treatment Type (Protein Supplements, Vitamin B12 Supplements, Vitamin D and Calcium Supplements), By Diagnostic Method (Biochemical Tests, I......maging Techniques, Functional Assessments, Others), By Distribution Channel (Hospital Pharmacies Source, Retail Pharmacies Source, Online Pharmacies Source, Other) and Others Read more

Healthcare
Dec 2024
Pages 186
Report Format: PDF, Excel, PPT

Market Definition

Sarcopenia is a kind of muscle loss that occurs with growing old and or immobility. It is characterized by the degenerative lack of skeletal muscle mass, quality, and strength. There is no medication to therapy Sarcopenia, however, some supplements may assist. Sarcopenia remedies include various services and products aimed at preventing, managing, or assuaging Sarcopenia. Protein, amino acids, fish oil, vitamin D, selenium, magnesium, and omega-3 supplements have proven promising effects in preventing muscle loss.

Market Insights & Analysis: Global Sarcopenia Treatment Market (2025-30):

The Global Sarcopenia Treatment Market size was valued at around USD 3 billion in 2024 and is projected to reach USD 3.9 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 4% during the forecast period, i.e., 2025-30. The Global Sarcopenia Treatment Market is experiencing significant growth driven by numerous key factors. Extended awareness of sarcopenia, particularly among aging populations, is encouraging early analysis and intervention. As a result, both healthcare specialists and patients are more actively managing muscle loss related to aging. Upgrades in nutritional supplements, which include amino acids, vitamin D, and protein-based products, are playing a pivotal function in fighting sarcopenia. These nutritional supplements are being more prescribed as a part of a holistic method of treatment, enhancing muscles and energy. Furthermore, government projects and healthcare programs for assisting the elderly people, are boosting the marketplace growth.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD 3 Billion
Market Value in 2030	USD 3.9 Billion
CAGR (2025-30)	4%
Leading Region	North America
Top Key Players	Pfizer Inc., Yeast Zydus Cadila, Ltd, Angel Yeast, Makers Nutrition LLC, Metabolic Technologies Inc., Metagenics LLC, Haleon Group of Companies, Abbott Laboratories, Nestlé SA, Eli Lilly, Sanofi Inc., Novartis AG, Amway Corporation, Bayer AG, and Others
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Additionally, the growing healthcare industry globally, especially in developed nations, is prompting investment into remedies for age-related problems, such as sarcopenia. Global health spending reached an astounding USD9.8 trillion in 2021 alone which accounted for 10.3% of the world's GDP. Moreover, the growth of internet-based pharmacies is increasing the availability of sarcopenia treatments, allowing patients to effortlessly get important supplements and medicines. The growing healthcare sector, particularly in the Asia-Pacific region, is driving growth in the market due to increasing urbanization and a growing old population contributing to rising demand for sarcopenia care.

At the same time, the enhancement of centered treatment options that boost muscular mass and reduce inflammation is enhancing the effectiveness of treatments. There is a growing attention to wellness programs for the elderly, which incorporate sarcopenia management into overall health initiatives, encouraging healthy aging. With the growing emphasis on preventative healthcare, the need for treatment options that can slow muscle degeneration is also growing. A combination of treatments, which pair dietary supplements with workout routines or drug treatment options, are demonstrating improved effectiveness in clinical trials. Furthermore, the growing recognition of nutraceuticals and functional food gives options for treating sarcopenia, which encourages innovation in the marketplace.

Market Segmentation
Introduction
1. Market Definition
2. Research Process
3. Assumption
Executive Summary
Global Sarcopenia Treatment Market Trends & Insights
Global Sarcopenia Treatment Market Dynamics
1. Growth Drivers
2. Challenges
Global Sarcopenia Treatment Market Hotspot & Opportunities
Global Sarcopenia Treatment Market Supply Chain Analysis
Global Sarcopenia Treatment Market Regulation & Policy
Global Sarcopenia Treatment Market Outlook, 2020-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Type
    1. Protein Supplements - Market Size & Forecast 2020-2030F, USD Million
    2. Vitamin B12 Supplements - Market Size & Forecast 2020-2030F, USD Million
    3. Vitamin D and Calcium Supplements - Market Size & Forecast 2020-2030F, USD Million
  2. By Diagnostic Method
    1. Biochemical Tests - Market Size & Forecast 2020-2030F, USD Million
    2. Imaging Techniques - Market Size & Forecast 2020-2030F, USD Million
    3. Functional Assessments - Market Size & Forecast 2020-2030F, USD Million
    4. Others - Market Size & Forecast 2020-2030F, USD Million
  3. By Distribution Channel
    1. Hospital Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
    2. Retail Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
    3. Online Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
    4. Other - Market Size & Forecast 2020-2030F, USD Million
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  5. By Competitors
    1. Competition Characteristics
    2. Market Share & Analysis

North America Sarcopenia Treatment Market Outlook, 2020- 2030
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
  2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
  3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
4. Canada Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
5. Mexico Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
South America Sarcopenia Treatment Market Outlook, 2020- 2030
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
  2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
  3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
  4. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
4. Argentina Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
Europe Sarcopenia Treatment Market Outlook, 2020- 2030
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
  2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
  3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. The UK Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
4. Germany Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
5. France Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
6. Italy Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
7. Spain Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
The Middle East & Africa Sarcopenia Treatment Market Outlook, 2020- 2030
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
  2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
  3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
  4. By Country
    1. Saudi Arabia
    2. The UAE
    3. South Africa
    4. Rest of The Middle East & Africa
3. Saudi Arabia Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
4. The UAE Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
5. South Africa Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
  3. By Industry- Market Size & Forecast 2020-2030F, USD Million
Asia-Pacific Sarcopenia Treatment Market Outlook, 2020- 2030
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
  2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
  3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
  4. By Country
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Australia
    6. Rest of Asia-Pacific
3. China Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
4. Japan Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
5. South Korea Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
6. India Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
7. Australia Sarcopenia Treatment Market Outlook, 2020-2030
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Treatment Type - Market Size & Forecast 2020-2030F, USD Million
    2. By Diagnostic Method - Market Size & Forecast 2020-2030F, USD Million
    3. By Distribution Channel - Market Size & Forecast 2020-2030F, USD Million
Global Sarcopenia Treatment Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Pfizer Inc.
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
2. Yeast Zydus Cadila, Ltd.
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
3. Angel Yeast
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
4. Makers Nutrition LLC
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
5. Metabolic Technologies Inc.
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
6. Metagenics LLC
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
7. Haleon Group of Companies
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
8. Abbott Laboratories
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
9. Nestlé SA
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
10. Eli Lilly
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
11. Sanofi Inc.
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
12. Novartis AG
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
13. Amway Corporation
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
14. Bayer AG
  1. Business Description
  2. Product Portfolio
  3. Strategic Alliances or Partnerships
  4. Recent Developments
  5. Financial Details
  6. Others
15. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying